Composition
- Active ingredients
- PEMETREXED DIPOTASSIUM EQ 500MG BASE/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- PEMETREXED DIPOTASSIUM EQ 100MG BASE/VIAL · PowderNDA210661-001 · Prescription
- PEMETREXED DIPOTASSIUM EQ 500MG BASE/VIAL · PowderThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA210661.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Axtle
- Active substance
- pemetrexed dipotassium
- Route
- Intravenous
- Dosage form
- Powder
- Applicant
- Avyxa Holdings
- Status
- Prescription
- FDA approval
- 28 Jun 2024
- Application
- NDA210661-002